Title:
癲癇の治療におけるカンナビノイドの使用
Document Type and Number:
Japanese Patent JP7303267
Kind Code:
B2
Abstract:
The present invention relates to the use of a therapeutically effective amount of cannabidiolic acid (CBDA) in the treatment of epilepsy. In one embodiment the CBDA is used in the treatment of generalised seizures, preferably tonic-clonic seizures.Preferably the CBDA used is in the form of a botanical drug substance in which the CBDA content is greater than 60%, and most preferably, it is a highly purified extract of cannabis such that the CBDA is present at greater than 95%, through 96% and 97% to most preferably, greater than 98% of the total extract (w/w) and the other components of the extract are characterised. In particular the cannabinoids tetrahydrocannabinol (THC) or tetrahydrocannabinol acid (THCA) have been substantially removed. Alternatively, the CBDA may be synthetically produced.
Inventors:
Colin Stott
Nicholas Jones
Robin williams
Benjamin Weirley
Nicholas Jones
Robin williams
Benjamin Weirley
Application Number:
JP2021153168A
Publication Date:
July 04, 2023
Filing Date:
September 21, 2021
Export Citation:
Assignee:
G.W.Research Limited
International Classes:
A61K31/192; A61K9/02; A61K9/12; A61K9/72; A61K31/05; A61K31/165; A61K31/19; A61K31/352; A61K31/357; A61K31/4015; A61K31/415; A61K31/423; A61K31/515; A61K31/5513; A61K45/00; A61P25/08; A61P43/00
Domestic Patent References:
| JP2013523708A | ||||
| JP2012532093A | ||||
| JP2014501271A |
Foreign References:
| US20050266108 |
Other References:
CBD-A: CANNABIDIOL ACID CANNABINOID PROFILE[ONLINE],2015年07月02日,検索日:2022年8月30日、URL:https://web.archive.org/web/20151020010230/https://www.whaxy.com/learn/can-the-CBD-A-cannabinoid-help-you
Attorney, Agent or Firm:
Yasuhiko Murayama
Shinya Mihiro
Tatsuhiko Abe
Shinya Mihiro
Tatsuhiko Abe